A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer

Clinical trial NCT01496742 · COMPLETED

Trial details

NCT number: NCT01496742
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Squamous Non-Small Cell Lung Cancer

Start date: 2012-04-01
Primary completion: 2015-11-01
Enrollment: 259

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.